Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Women diagnosed with breast cancer are 39% more likely to develop second cancer

Women diagnosed with invasive breast cancer are 39% more likely to develop a second cancer in a different part of the body. Such is the conclusion of a recent study, pioneered by female Spanish researchers.

18 Oct 2013

Combination of heat, doxorubicin drug and nanotech system may improve ovarian cancer treatment

The combination of heat, chemotherapeutic drugs and an innovative delivery system based on nanotechnology may significantly improve the treatment of ovarian cancer while reducing side effects from toxic drugs, researchers at Oregon State University report in a new study.

18 Oct 2013

Scientists identify 127 mutated genes that appear to drive development of tumors in the body

Examining 12 major types of cancer, scientists at Washington University School of Medicine in St. Louis have identified 127 repeatedly mutated genes that appear to drive the development and progression of a range of tumors in the body. The discovery sets the stage for devising new diagnostic tools and more personalized cancer treatments.

17 Oct 2013

Researchers discover why women with BRCA gene develop breast and ovarian cancer

Researchers announced today in the journal Lancet Oncology that they are well on the way to discovering why women with the faulty genes BRCA 1 and BRCA 2, one of which was inherited by the actress Angelina Jolie, develop breast and ovarian cancer rather than other cancers.

17 Oct 2013

Results announced for Phase II PRECEDENT trial of vintafolide for treatment of platinum-resistant ovarian cancer

Merck, known as MSD outside the United States and Canada, (NYSE: MRK) and Endocyte, Inc. (NASDAQ: ECYT) today announced the online publication of results from the randomized Phase II PRECEDENT trial for vintafolide (MK-8109/EC145), an investigational folate small molecule drug conjugate (SMDC), in the Journal of Clinical Oncology (JCO), the official journal of the American Society of Clinical Oncology.

15 Oct 2013

PARP inhibitor drugs and chemotherapy can help women with ovarian cancer live longer

Conventional chemotherapy could further extend life in some women with ovarian cancer when used in tandem with a new type of targeted treatment, a new international study shows.

13 Oct 2013

Cedars-Sinai woman researcher puts extensive effort to increase awareness on ovarian cancer research

Julie Miller is a key part of an extensive effort at Cedars-Sinai to increase awareness of and support for women's cancer research. She not only has registered to participate in clinical research, but she's also lacing up her running shoes.

11 Oct 2013

Next-generation sequencing technology effective for detecting BRCA1 and BRCA2 mutations

The recognition of a causal link between mutations in BRCA1 and BRCA2 genes and increased risk of developing breast and ovarian cancer has intensified the demand for genetic testing. Identifying mutations in these large genes by conventional methods can be time consuming and costly.

9 Oct 2013

Women with recurrent ovarian cancer survive longer after treatment with cediranib

Women with ovarian cancer that has recurred after chemotherapy have survived for longer after treatment with a biological therapy called cediranib, according to new results to be presented today (Monday) at the 2013 European Cancer Congress.

30 Sep 2013

Pan-Cancer Initiative: Patterns Emerge Across Diverse Tumor Types

...

27 Sep 2013

Mayo Clinic experts to discuss risk factors, screening and treatments for breast cancer

October is National Breast Cancer Awareness Month, and Mayo Clinic breast cancer experts are available to discuss risk factors, screening and treatments.

27 Sep 2013

Applied Integrin Sciences' drug candidate eliminates ovarian cancer tumors in pre-clinical study

Applied Integrin Sciences, Inc. announced today that its first cancer therapeutic drug candidate eliminated all intraperitoneal ovarian cancer tumors in a pre-clinical study testing a novel treatment regimen.

21 Sep 2013

Dog food preservative may prevent nerve damage in patients taking chemotherapy

Working with cells in test tubes and in mice, researchers at Johns Hopkins have discovered that a chemical commonly used as a dog food preservative may prevent the kind of painful nerve damage found in the hands and feet of four out of five cancer patients taking the chemotherapy drug Taxol.

20 Sep 2013

Lifescript.com, Cedars-Sinai join to produce Web video series focusing on women's health

Cedars-Sinai, the largest academic medical center in California, and Lifescript.com, a leading women's health and wellness website, announced today they are co-producing a Web video series focused on women's health, medical news and innovations.

18 Sep 2013

New approach subtypes cancers by shared genetic effects; a step toward personalized medicine

Cancer tumors almost never share the exact same genetic mutations, a fact that has confounded scientific efforts to better categorize cancer types and develop more targeted, effective treatments.

16 Sep 2013

Family Gene Toolkit may help families communicate about mutation, cancer risk and genetic testing

Actress Angelina Jolie made headlines in May when she revealed she underwent a preventive double mastectomy to reduce her risk of cancer.

12 Sep 2013

Elevated miR-200 boosts survival of lung, ovarian, renal, triple-negative breast cancer patients

A family of microRNAs (miR-200) blocks cancer progression and metastasis by stifling a tumor's ability to weave new blood vessels to support itself, researchers at The University of Texas MD Anderson Cancer Center report today in Nature Communications.

12 Sep 2013

Researchers identify genetic link specific to risk of childhood leukemia

For the first time, a genetic link specific to risk of childhood leukemia has been identified, according to a team of researchers from Memorial Sloan-Kettering Cancer Center, St. Jude Children's Research Hospital, University of Washington, and other institutions. The discovery was reported online today in the journal Nature Genetics.

10 Sep 2013

Endocyte, Nihon Medi-Physics Collaborate On Companion Imaging Diagnostic

...

6 Sep 2013

Endocyte, Nihon Medi-Physics Collaborate On Companion Imaging Diagnostic

...

6 Sep 2013

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Women diagnosed with breast cancer are 39% more likely to develop second cancer

Combination of heat, doxorubicin drug and nanotech system may improve ovarian cancer treatment

Scientists identify 127 mutated genes that appear to drive development of tumors in the body

Researchers discover why women with BRCA gene develop breast and ovarian cancer

Results announced for Phase II PRECEDENT trial of vintafolide for treatment of platinum-resistant ovarian cancer

PARP inhibitor drugs and chemotherapy can help women with ovarian cancer live longer

Cedars-Sinai woman researcher puts extensive effort to increase awareness on ovarian cancer research

Next-generation sequencing technology effective for detecting BRCA1 and BRCA2 mutations

Women with recurrent ovarian cancer survive longer after treatment with cediranib

Pan-Cancer Initiative: Patterns Emerge Across Diverse Tumor Types

Mayo Clinic experts to discuss risk factors, screening and treatments for breast cancer

Applied Integrin Sciences' drug candidate eliminates ovarian cancer tumors in pre-clinical study

Dog food preservative may prevent nerve damage in patients taking chemotherapy

Lifescript.com, Cedars-Sinai join to produce Web video series focusing on women's health

New approach subtypes cancers by shared genetic effects; a step toward personalized medicine

Family Gene Toolkit may help families communicate about mutation, cancer risk and genetic testing

Elevated miR-200 boosts survival of lung, ovarian, renal, triple-negative breast cancer patients

Researchers identify genetic link specific to risk of childhood leukemia

Endocyte, Nihon Medi-Physics Collaborate On Companion Imaging Diagnostic

Endocyte, Nihon Medi-Physics Collaborate On Companion Imaging Diagnostic

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in